Immutep S.A.S.

Quick facts

Phase 3 pipeline

• cisplatin or carboplatin + pemetrexed · Oncology
  This combination uses platinum-based chemotherapy (cisplatin or carboplatin) plus pemetrexed, a folate antagonist that inhibits multiple enzymes in nucleotide synthesis, to damage cancer cell DNA and disrupt cell division.

Phase 2 pipeline

• eftilagimod alpha

Phase 1 pipeline

• IMP321
• IMP761

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Immutep S.A.S. portfolio CI brief
• Immutep S.A.S. pipeline updates RSS